Dose distribution displacement device design method, storage medium, terminal and computer program product for BNCT

The dose distribution regulator data is optimized through genetic algorithms, combined with Monte Carlo software to simulate thermal neutron flux distribution, and a dose distribution displacement device with the smallest fitness value is designed, which solves the problem that the maximum thermal neutron flux value in the BNCT device cannot be located in the tumor The central problem achieves precise treatment of tumors and protection of normal tissues.

CN118486473BActive Publication Date: 2024-11-08HUAPENG NEUTRON TECH (HANGZHOU) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410948483.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-07-16
Publication Date
2024-11-08
Estimated Expiration
2044-07-16

AI Technical Summary

Technical Problem

The beam shaping material and structure of existing BNCT devices are difficult to change, making the maximum value of thermal neutron flux unable to be located at the center of tumors at different depths, resulting in poor treatment effect.

Method used

The dose distribution regulator data is optimized by genetic algorithm, and the initial data is randomly generated, and iteratively optimized material type and thickness. Combined with Monte Carlo software to simulate thermal neutron flux distribution, a dose distribution displacement device with the smallest fitness value is designed to ensure thermal The maximum neutron flux is located at the depth of the tumor center.

Benefits of technology

There is no need to change the original beam shaping structure, so as to achieve maximum thermal neutron flux deposition at the center of the tumor, improve the tumor killing effect, reduce damage to normal tissues, and achieve accurate treatment of tumors at different depths.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118486473B_ABST
    Figure CN118486473B_ABST
Patent Text Reader

Abstract

The present invention discloses a design method, storage medium, terminal and computer program product for a dose distribution displacement device for BNCT, wherein the method comprises generating a plurality of initial dose distribution regulator data, forming an iterative data group with the initial dose distribution regulator data; iteratively optimizing the iterative data group to obtain an optimized iterative data group, taking the dose distribution regulator data with the smallest fitness value in the optimized iterative data group as a design scheme for a dose distribution displacement device, wherein the dose distribution displacement device is formed by sequentially stacking various layers of materials obtained based on the design scheme for the dose distribution displacement device; the fitness value acquisition process of the dose distribution regulator data sets the tumor center depth as an optimization target. The present invention can optimize the material type and material thickness of the dose distribution displacement device according to different tumor center depths in the recipient, so that the maximum dose caused by thermal neutrons is deposited at the tumor center position, achieving maximum lethality to tumor bacteria.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of medical technology, and in particular to a design method, storage medium, terminal and computer program product of a dose distribution displacement device for BNCT. Background Art

[0002] Boron Neutron Capture Therapy (BNCT) is a new method for achieving precision cancer treatment with the characteristics of binary targeting. During BNCT treatment, a boron (10B) drug is first injected into the tumor receptor. The drug has a strong affinity with tumors and can selectively accumulate in cancer cells, but is less distributed in normal tissues. Then, a neutron beam mainly composed of epithermal neutrons (0.5e-6 MeV < Eepi < 1e-2 MeV) generated by a reactor or accelerator and optimized by a beam shaping assembly (BSA) is used to irradiate the lesion. The epithermal neutrons are slowed down when passing through human tissues and gradually become a neutron beam mainly composed of thermal neutrons (Eth < 0.5e-6 MeV). Thermal neutrons have a high reaction cross-section with 10B enriched in tumors, and the following reaction occurs at the cellular scale: 10B+n→α+7Li+0.478MeV. The generated α particles and 7Li particles have extremely high linear energy transfer (LET), with average LET of 164 keV / μm and 151 keV / μm, respectively, and a range of 4-10 μm, which is comparable to the scale of cells. Therefore, this method can kill cancer cells accurately and efficiently at the cellular scale.

[0003] That is, BNCT mainly uses thermal neutrons to react with boron, nitrogen, hydrogen and other elements in the human body to cause secondary particles and deposit energy at the lesion site to achieve the purpose of treatment. To maximize the therapeutic effect of BNCT, it is necessary to make the neutrons at the beam outlet moderated by the human body to produce thermal neutrons, and the maximum value of the thermal neutron flux is exactly located at the center of the tumor; at this time, the dose caused by the neutrons at the center of the tumor is the largest, the killing effect on the tumor is the strongest, and the damage to normal tissue is the smallest. In theory, this purpose can be achieved by changing the material and structure of the beam moderator BSA and adjusting the neutron energy spectrum at the beam outlet. However, since the volume of the beam moderator of the accelerator neutron source is usually very large, it is difficult to install and disassemble frequently, so the neutron energy spectrum at the exit of the beam moderator BSA is usually determined.

[0004] Since different neutron energy spectra need to be modulated for tumors with different receptors and different depths, there is an urgent need for a design of a device that can achieve modulation for tumors with different receptors and different depths. Summary of the invention

[0005] The purpose of the present application is to provide a design method, storage medium, terminal and computer program product for a dose distribution displacement device for BNCT, which is used to solve the problem in the prior art that it is difficult to change the material and structure of the beam shaping body of the BNCT device, so that the maximum value of the thermal neutron flux cannot be located at the center of the tumor at different depths.

[0006] In a first aspect, the present application provides a method for designing a dose distribution displacement device for BNCT, comprising:

[0007] Randomly generate a plurality of initial dose distribution adjuster data, wherein the initial dose distribution adjuster data includes the material type of each layer and the thickness of each layer, and all the initial dose distribution adjuster data constitute an iterative data group;

[0008] Iteratively optimize the iterative data group by using a genetic algorithm to obtain an optimized iterative data group, and use the dose distribution adjuster data with the smallest fitness value in the optimized iterative data group as a dose distribution displacement device design scheme;

[0009] Among them, the dose distribution displacement device is formed by stacking layers of materials obtained based on the design scheme of the dose distribution displacement device in sequence; the fitness value acquisition process of the dose distribution regulator data sets the tumor center depth as the optimization target; the size of the fitness value is linearly related to the distance between the depth of the maximum value of the thermal neutron flux in the recipient body and the depth of the tumor center.

[0010] In one embodiment of the present application, randomly generating a plurality of initial dose distribution adjuster data includes:

[0011] Acquire all candidate materials for constructing a dose distribution adjuster, and number all the candidate materials;

[0012] Randomly generate multiple number groups, select materials from all the candidate materials based on the numbers in the number groups to form a material layer, so as to obtain material distribution data corresponding to each number group;

[0013] The thickness of each material layer in each material distribution data is randomly generated to obtain initial dose distribution regulator data corresponding to each material distribution data.

[0014] In one embodiment of the present application, the iterative data set is iteratively optimized by a genetic algorithm, and obtaining the optimized iterative data set includes:

[0015] The current iterative data group is used as the existing population in the genetic algorithm, a new population is generated based on the existing population, and the new population is used as the new round of iterative data group;

[0016] Determine whether the new round of iterative data group meets the iteration termination condition, if so, use the new round of iterative data group as the optimized iterative data group, otherwise use the new round of iterative data group as the current iterative data group, and re-acquire the new round of iterative data group based on the current iterative data group. In one embodiment of the present application, use the current iterative data group as an existing population in the genetic algorithm, generate a new population based on the existing population, and use the new population as the new round of iterative data group includes:

[0017] The current iterative data group is used as the existing population in the genetic algorithm, and based on the fitness value of the dose distribution regulator data, some dose distribution regulator data are selected from the existing population for crossover mutation to obtain multiple dose distribution regulator data after crossover mutation, and based on the fitness value of the dose distribution regulator data, some dose distribution regulator data are selected from the existing population and all the dose distribution regulator data after crossover mutation to form a new population, and the new population is used as a new round of iterative data group.

[0018] In one embodiment of the present application, selecting part of the dose distribution adjuster data from the existing population based on the fitness value of the dose distribution adjuster data for crossover mutation includes:

[0019] Based on the fitness value in ascending order, multiple dose distribution regulator data are screened from the existing population, the material types of the multiple dose distribution regulator data are crossed and mutated, and the material thickness of the multiple dose distribution regulator data after the material type cross-mutation is crossed and mutated.

[0020] In one embodiment of the present application, the iteration termination condition is that the current iteration number is greater than a preset iteration number or there is dose distribution adjuster data with a fitness value greater than a preset fitness threshold in the new round of iteration data group.

[0021] In one embodiment of the present application, the process of obtaining the fitness value of the dose distribution adjuster data is as follows:

[0022] Modeling is performed in Monte Carlo software based on the dose distribution adjuster data and running the model to obtain thermal neutron flux distribution data corresponding to the dose distribution adjuster data, and the fitness value corresponding to the dose distribution adjuster data is obtained from the thermal neutron flux distribution data, and the Monte Carlo software sets the tumor center depth as the optimization target.

[0023] In one embodiment of the present application, the fitness value is obtained based on the fitness function calculation, and the fitness function expression is:

[0024]

[0025] Among them, OBJ represents the fitness value, A and B both represent weight factors, represents the distance between the depth of the maximum thermal neutron flux in the recipient body and the depth of the tumor center, Indicates the maximum thermal neutron flux value in the receptor body.

[0026] In a second aspect, the present application provides a storage medium having a computer program stored thereon, which, when executed by a processor, implements the method for designing a dose distribution displacement device for BNCT.

[0027] In a third aspect, the present application provides a terminal, including: a processor and a memory, wherein the memory is communicatively connected to the processor;

[0028] The memory is used to store a computer program, and the processor is used to execute the computer program stored in the memory, so that the terminal executes the method for designing a dose distribution displacement device for BNCT as described in the implementation.

[0029] In a fourth aspect, the present application provides a computer program product, including a computer program, which, when executed by a processor, implements the method for designing a dose distribution displacement device for BNCT.

[0030] Compared with the prior art, one or more embodiments of the above scheme may have the following advantages or beneficial effects:

[0031] By using the design method of the dose distribution displacement device for BNCT provided by the embodiment of the present invention, there is no need to change the original beam shaping body structure, and the material type and material thickness of the dose distribution displacement device can be optimized for different tumor center depths in the recipient, so that after the dose distribution displacement device based on the optimized design is applied to the beam shaping body of the corresponding BNCT device, the maximum dose caused by thermal neutrons is deposited at the center of the tumor, achieving the maximum killing effect on the tumor and the minimum damage to normal tissue, thereby achieving precise treatment of different types of tumors at different tumor center depths. The design method of the present invention selects a combination of different materials and different thicknesses, and realizes the search for the optimal model by simultaneously changing the material type and material thickness. The design method of the present invention has strong operability and flexibility, and also has the advantages of simple operation, stable effect, safety and effectiveness.

[0032] Other features and advantages of the present invention will be described in the following description, and partly become apparent from the description, or understood by practicing the present invention. The purpose and other advantages of the present invention can be realized and obtained by the structures particularly pointed out in the description, claims and drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] The accompanying drawings are used to provide a further understanding of the present invention and constitute a part of the specification. Together with the embodiments of the present invention, they are used to explain the present invention and do not constitute a limitation of the present invention. In the accompanying drawings:

[0034] Figure 1 Shown is a schematic flow chart of a method for designing a dose distribution displacement device for BNCT as described in an embodiment of the present application.

[0035] Figure 2 Shown is a process schematic diagram of a method for designing a dose distribution displacement device for BNCT as described in an embodiment of the present application.

[0036] Figure 3 It shows a schematic diagram of the structure of a dose distribution displacement device installed in a beam shaping body of a BNCT device in an embodiment of the present application; Figure 3 (a) shows the overall structure of the beam shaping body equipped with a dose distribution displacement device. Figure 3 (b) shows Figure 3 (a) is an enlarged schematic diagram of the neutron beam outlet part (i.e. part A) of the beam shaper.

[0037] Figure 4 It shows a schematic diagram of thermal neutron flux distribution when DDS is not used and when a dose distribution displacement device designed by the dose distribution displacement device design method for BNCT described in an embodiment of the present application is used.

[0038] Figure 5 Shown is a schematic diagram of the structure of the terminal described in an embodiment of the present application. DETAILED DESCRIPTION

[0039] The following describes the embodiments of the present application through specific examples, and those skilled in the art can easily understand other advantages and effects of the present application from the contents disclosed in this specification. The present application can also be implemented or applied through other different specific embodiments, and the details in this specification can also be modified or changed in various ways based on different viewpoints and applications without departing from the spirit of the present application. It should be noted that the following embodiments and features in the embodiments can be combined with each other without conflict.

[0040] It should be noted that the illustrations provided in the following embodiments are only schematic illustrations of the basic concept of the present application, and thus the drawings only show components related to the present application rather than being drawn according to the number, shape and size of components in actual implementation. In actual implementation, the type, quantity and proportion of each component may be changed at will, and the component layout may also be more complicated.

[0041] The following embodiments of the present application provide a design method, storage medium, terminal and computer program product for a dose distribution displacement device for BNCT, which is used to solve the problem in the prior art that it is difficult to change the material and structure of the beam shaping body of the BNCT device, so that the maximum value of the thermal neutron flux cannot be located at the center of the tumor at different depths.

[0042] like Figure 1 and Figure 2 As shown, this embodiment provides a method for designing a dose distribution displacement device for BNCT, comprising the following steps.

[0043] Step S101 , randomly generating a plurality of initial dose distribution adjuster data, the initial dose distribution adjuster data including the material type of each layer and the thickness of each layer, and all the initial dose distribution adjuster data constitute an iterative data group.

[0044] Specifically, all materials that can be used to construct a dose distribution regulator are selected as candidate materials for the dose distribution regulator. All materials suitable for neutron moderation and absorption can be used as candidate materials. Since hydrogen-containing materials combined with thermal neutron absorbers can realize the function of thermal neutron distribution regulation, the candidate materials for the dose distribution regulator are preferably hydrogen-containing materials. For example, the candidate materials for the dose distribution regulator may include moderation materials such as polyethylene, water, acrylic acid, boron-containing polyethylene, and boron carbide. Obtain all available candidate materials for the dose distribution regulator under the current conditions, and number all the obtained candidate materials so that all candidate materials have different numbers.

[0045] Based on the numbering of the current candidate materials, multiple groups of numbering groups are randomly generated, each group of numbering groups has multiple numbers, and then based on the candidate materials corresponding to the numbers in each group of numbering groups, the material distribution data corresponding to each group of numbering groups is generated. For example, assuming that polyethylene is numbered 1, water is numbered 2, acrylic acid is numbered 3, boron-containing polyethylene is numbered 4, and boron carbide is numbered 5, then the material distribution data corresponding to the numbering groups 1-3-5 are polyethylene, acrylic acid, and boron carbide. Based on experimental data, it can be seen that designing the number of material layers in the dose distribution regulator data as 3 layers is easier to achieve the maximum dose caused by thermal neutrons deposited at the center of the tumor than setting it to other layers. Therefore, the number of material layers in the dose distribution regulator data is preferably designed to be 3 layers, and there are 3 numbers in each numbering group. Then, the thickness of each material in each material distribution data is randomly generated within a preset range, and then the initial dose distribution regulator data corresponding to each material distribution data is obtained. Further, the preset range of the random thickness of each candidate material in each material distribution data can be set to 0-3cm. Each of the initial dose distribution adjuster data thus obtained has a fixed material type and each type of material has a fixed thickness. After obtaining a plurality of initial dose distribution adjuster data, all the plurality of initial dose distribution adjuster data need to be combined into an iterative data set.

[0046] Step S102, iteratively optimize the iterative data set by genetic algorithm, obtain the optimized iterative data set, and use the dose distribution adjuster data with the smallest fitness value in the optimized iterative data set as the dose distribution displacement device design scheme. This step specifically includes sub-step S201 and step S202.

[0047] Step S201, obtaining the current iteration data group to obtain the new round of iteration data group.

[0048] Specifically, the current iterative data group is first used as the existing population in the genetic algorithm, and the fitness value of each dose distribution regulator data in the current iterative data group is first calculated, and then part of the dose distribution regulator data is screened out from the current iterative data group based on the fitness value in ascending order, and then the screened dose distribution regulator data is cross-mutated to obtain multiple dose distribution regulator data after cross-mutation. Secondly, the fitness value of all cross-mutated dose distribution regulator data is obtained, and on the basis of all dose distribution regulator data in the current iterative data group and all cross-mutated dose distribution regulator data, part of the dose distribution regulator data is screened out based on the fitness value in ascending order to form a new population, and the new population is used as a new round of iterative data group.

[0049] The cross-mutation of the selected dose distribution regulator data specifically includes: cross-mutating and mutating the material type of the selected dose distribution regulator data to obtain the dose distribution regulator data after the cross-mutation of the material type; and then cross-mutating and mutating the material thickness of the dose distribution regulator data after the cross-mutation of the material type to obtain multiple cross-mutated dose distribution regulator data. It should be noted that the material thickness of the dose distribution regulator data can also be cross-mutated first, and then the material type of the dose distribution regulator data can be cross-mutated.

[0050] The fitness value of the dose distribution regulator data is obtained in the following way: based on the dose distribution regulator data, a model is built in the Monte Carlo software (MCNP) to obtain a simulated dose distribution regulator, and then the Monte Carlo software is run to output the thermal neutron flux distribution data when the simulated dose distribution regulator is set at the neutron outlet of the beam shaper in the BNCT device, that is, the thermal neutron flux distribution data corresponding to the dose distribution regulator data is obtained; then the programming software MATLAB reads the thermal neutron flux distribution data file output by the Monte Carlo software, and extracts the calculation results to output the fitness value of the dose distribution regulator data.

[0051] It should be noted that the above-mentioned Monte Carlo software sets the depth of the tumor center as the optimization target. The depth of the tumor center is the depth of the tumor center of the tumor to be treated in the current patient. The preset depth of the tumor center can be set to different values ​​based on the actual situation of the recipient tumor. And the fitness value of the dose distribution regulator data needs to be set to be linearly related to the distance between the depth of the maximum value of the thermal neutron flux in the recipient body and the depth of the tumor center. The specific fitness value is obtained based on the fitness function calculation. The fitness function expression of the programming software MATLAB is designed as:

[0052]

[0053] Among them, OBJ represents the fitness value. The lower the fitness value, the closer the individual is to the set optimization target. A and B both represent weight factors. When optimizing different targets, the weight factors can be adjusted according to the importance of different optimization targets, and the weight factors can be set to negative numbers. represents the distance between the depth of the maximum thermal neutron flux in the recipient body and the depth of the tumor center, It represents the maximum thermal neutron flux value in the receptor body, which is obtained based on the outlet neutron energy spectrum of the beam shaper in the current BNCT device.

[0054] The fitness value of each dose distribution adjuster data in the current iteration data group and the fitness values ​​of all mutated dose distribution adjuster data are obtained in the above manner.

[0055] Step S202, determine whether the new round of iterative data group meets the iteration termination condition. If so, select the dose distribution adjuster data with the smallest fitness value in the new round of iterative data group as the dose distribution displacement device design scheme; otherwise, use the new round of iterative data group as the current iterative data group, and re-obtain a new round of iterative data group based on the current iterative data group.

[0056] Specifically, it is determined whether the newly acquired new round of iterative data group satisfies the iteration termination condition, and further it is determined whether the number of iterations to which the acquired new round of iterative data group belongs (i.e., the number of iterations currently performed) is greater than the preset number of iterations. If so, it means that the current number of iterations has reached a sufficient number, and the dose distribution adjuster data with the smallest fitness value in the new round of iterative data group is selected as the design scheme of the dose distribution displacement device; otherwise, it means that the current number of iterations has not yet met the requirements, and the newly acquired new round of iterative data group is required to be used as the current iterative data group, and step S201 is re-executed to obtain a new new round of iterative data group (i.e., a new round of iterative data group is obtained based on the current iterative data group). It should be noted that the above-mentioned iteration termination condition can also be set as the presence of dose distribution adjuster data with a fitness value greater than a preset fitness threshold in the new round of iteration data group, that is, it is determined whether there is dose distribution adjuster data with a fitness value greater than the preset fitness threshold in the latest acquired new round of iteration data group. If so, it means that a dose distribution displacement device design scheme that meets the requirements has been found. At this time, the dose distribution adjuster data with the smallest fitness value in the new round of iteration data group is selected as the design scheme of the dose distribution displacement device. Otherwise, it means that the new round of iteration data group does not have a dose distribution displacement device design scheme that meets the requirements. At this time, the latest acquired new round of iteration data group is used as the current iteration data group, and step S102 is re-executed to obtain a new new round of iteration data group (that is, a new round of iteration data group is obtained based on the current iteration data group).

[0057] Furthermore, the above two iteration termination conditions may exist at the same time, that is, the iteration can be stopped when any one of the above two termination conditions is met during the judgment.

[0058] After obtaining the design scheme of the dose distribution displacement device, a dose distribution displacement device (DDS) can be constructed based on the material type and thickness of each layer in the design scheme of the dose distribution displacement device. Specifically, each layer of material is first obtained based on the material type and thickness of each layer in the design scheme of the dose distribution displacement device, and then the obtained layers of material are sequentially stacked to form a dose distribution displacement device. The overall structure of the dose distribution displacement device can be designed into various shapes based on actual needs, and there are no excessive restrictions on it here. The dose distribution displacement device constructed based on the design scheme of the dose distribution displacement device obtained in this embodiment is installed at the neutron beam outlet of the beam shaper (BSA) of the BNCT device when in use, and the layers of material constituting the dose distribution displacement device are sequentially stacked along the neutron emission direction of the beam shaper. Figure 3 A schematic diagram of the structure of a dose distribution displacement device installed on a beam shaping body of a BNCT device is shown, wherein Figure 3 (a) shows the overall structure of the beam shaping body equipped with a dose distribution shifting device (DDS). Figure 3 (b) shows Figure 3 (a) is an enlarged schematic diagram of the neutron beam outlet part (i.e. part A) of the beam shaper. Figure 3 The dose distribution displacement device shown in (b) is composed of three layers of materials. The dose distribution displacement device set at the neutron exit of the beam shaping body (BSA) can modulate the neutron energy spectrum at the exit of the beam shaping body (BSA) so that the maximum dose caused by thermal neutrons is deposited at the center of the tumor, achieving the maximum killing effect on the tumor and the minimum damage to normal tissues, thereby achieving precise treatment of different types of tumors at different tumor center depths.

[0059] In order to describe the design method of the dose distribution displacement device for BNCT in the embodiment of the present invention in more detail. The embodiment of the present invention provides the relationship between the thermal neutron flux and the receptor depth when the dose distribution displacement device (DDS) is not used, and the relationship between the thermal neutron flux and the receptor depth corresponding to the dose distribution displacement device designed for three tumor center depths of 0 cm, 1.3 cm and 3.4 cm (taking the material layer number in the dose distribution displacement device as 3 layers as an example), as shown in FIG. Figure 4 As shown, Figure 4 The receptor depth corresponding to the horizontal axis is the depth from the receptor surface, and Figure 4 The corresponding material and thickness information of each layer of each type of DDS is also given. Figure 4It can be seen that when the dose distribution shift device (DDS) designed by the dose distribution shift device design method for BNCT according to the embodiment of the present invention is not adopted, the receptor depth when the thermal neutron flux is maximum is 2.3 cm; if the position with the maximum thermal neutron flux is to be shifted toward the superficial direction of the receptor to 1.3 cm away from the skin and just at the skin surface (0 cm), 1 cm of PE and 3 cm of PE are required respectively (at this time, the three layers of material in the dose distribution shift device for the two cases are all PE materials, and the above number of centimeters is the total thickness of the DDS); and when the maximum position of the thermal neutron flux distribution is moved to a deep position of 3.4 cm, a combination of 2 cm PE+1 cm B4C is required (the dose distribution shift device for this case can be composed of 2 layers of PE material and 1 layer of B4C material, or composed of 1 layer of PE material and 2 layers of B4C material, and the above number of centimeters is the total thickness of the corresponding materials). Therefore, it is proved that the dose distribution displacement device designed by the dose distribution displacement device design method for BNCT according to the embodiment of the present invention can realize the modulation of thermal neutron flux dose distribution in the human body, and has the function of optimizing the treatment effect of tumors at different depths.

[0060] The method of the present invention essentially adopts a method combining genetic algorithm and Monte Carlo software (MCNP), takes the specific depth of the center of the tumor at different depths in the human body as the optimization target, realizes the neutron energy spectrum modulation of the beam shaping body outlet of the BNCT device by optimizing the type and thickness of the DDS material, and finally realizes the adjustment of the dose distribution in the human body, so that the maximum value of the thermal neutron flux is located exactly at the center of the tumor, so as to achieve the strongest tumor killing effect and the smallest normal tissue damage.

[0061] The design method of the dose distribution displacement device for BNCT provided in the embodiment of the present invention does not need to change the original beam shaping body structure, and can optimize the material type and material thickness of the dose distribution displacement device according to different tumor center depths in the recipient, so that after the dose distribution displacement device based on the optimized design is applied to the beam shaping body of the corresponding BNCT device, the maximum dose caused by thermal neutrons is deposited at the center of the tumor, achieving the maximum killing effect on the tumor and the minimum damage to normal tissue, and realizing the precise treatment of different types of tumors at different tumor center depths. The design method of the present invention selects a combination of different materials and different thicknesses, and realizes the search for the optimal model by simultaneously changing the material type and material thickness. The design method of the present invention has strong operability and flexibility, and also has the advantages of simple operation, stable effect, safety and effectiveness.

[0062] The embodiment of the present application also provides a computer-readable storage medium. A person of ordinary skill in the art can understand that all or part of the steps in the above-mentioned embodiment method can be completed by instructing the processor through a program, and the program can be stored in a computer-readable storage medium, and the storage medium is a non-transitory medium, such as a random access memory, a read-only memory, a flash memory, a hard disk, a solid-state hard disk, a magnetic tape, a floppy disk, an optical disc, and any combination thereof. The above-mentioned storage medium can be any available medium that can be accessed by a computer or a data storage device such as a server or a data center that includes one or more available media integrated. The available medium can be a magnetic medium (for example, a floppy disk, a hard disk, a tape), an optical medium (for example, a digital video disc (DVD)), or a semiconductor medium (for example, a solid-state disk (SSD)), etc.

[0063] like Figure 5 As shown, an embodiment of the present application provides a terminal.

[0064] The terminal of this embodiment includes a processor and a memory connected to each other; the memory is used to store computer programs, and the processor is used to execute the computer programs stored in the memory, so that all or part of the steps in the method of the above embodiment can be implemented when the terminal executes.

[0065] The beneficial effects of all or part of the steps of the method in the above embodiment are the same as the beneficial effects obtained by applying the terminal provided by the embodiment of the present invention, and will not be described in detail here.

[0066] It should be noted that the memory may include random access memory (RAM) and may also include non-volatile memory, such as at least one disk storage. Similarly, the processor may also be a general-purpose processor, including a central processing unit (CPU), a network processor (NP), etc.; it may also be a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA) or other programmable logic devices, discrete gates or transistor logic devices, discrete hardware components.

[0067] The present application also provides a computer program product, which stores computer-readable instructions. The computer-readable instructions can be executed by at least one processor to enable the at least one processor to execute all or part of the steps in the above-mentioned embodiment method.

[0068] The beneficial effects of all or part of the steps of the method in the above embodiment are the same as the beneficial effects obtained by applying the computer program product provided by the embodiment of the present invention, and will not be described in detail here.

[0069] Although the embodiments disclosed in the present invention are as above, the contents described are only embodiments adopted for facilitating the understanding of the present invention and are not intended to limit the present invention. Any technician in the technical field to which the present invention belongs can make any modifications and changes in the form and details of the implementation without departing from the spirit and scope disclosed in the present invention, but the protection scope of the present invention shall still be subject to the scope defined in the attached claims.

Claims

1. A method for designing a dose distribution displacement device for BNCT, comprising: Randomly generate a plurality of initial dose distribution adjuster data, wherein the initial dose distribution adjuster data includes the material type of each layer and the thickness of each layer, and all the initial dose distribution adjuster data constitute an iterative data group; Iteratively optimize the iterative data group by using a genetic algorithm to obtain an optimized iterative data group, and use the dose distribution adjuster data with the smallest fitness value in the optimized iterative data group as a dose distribution displacement device design scheme; The dose distribution displacement device is formed by stacking layers of materials obtained based on the design scheme of the dose distribution displacement device in sequence; the fitness value acquisition process of the dose distribution regulator data sets the tumor center depth as the optimization target; the fitness value is linearly related to the distance between the maximum depth of the thermal neutron flux in the recipient body and the tumor center depth; The process of obtaining the fitness value of the dose distribution regulator data is as follows: Modeling and running in Monte Carlo software based on dose distribution regulator data to obtain thermal neutron flux distribution data corresponding to the dose distribution regulator data, obtaining a fitness value corresponding to the dose distribution regulator data through the thermal neutron flux distribution data, and the Monte Carlo software sets the tumor center depth as an optimization target; The fitness value is obtained based on the fitness function calculation, and the fitness function expression is: OBJ=A·|D thcrmal-max -D tumor |+B·F thcrmal-max Among them, OBJ represents the fitness value, A and B represent weight factors, |D thcrmal-max -D tumor | represents the distance between the depth of the maximum thermal neutron flux in the recipient body and the depth of the tumor center, F thermal-max Indicates the maximum thermal neutron flux value in the receptor body.

2. The design method according to claim 1, characterized in that: Randomly generate multiple initial dose distribution modifier data including: Acquire all candidate materials for constructing a dose distribution adjuster, and number all the candidate materials; Randomly generate multiple number groups, select materials from all the candidate materials based on the numbers in the number groups to form a material layer, so as to obtain material distribution data corresponding to each number group; The thickness of each material layer in each material distribution data is randomly generated to obtain initial dose distribution regulator data corresponding to each material distribution data.

3. The design method according to claim 1, characterized in that: Iteratively optimizing the iterative data set by using a genetic algorithm to obtain an optimized iterative data set includes: The current iterative data group is used as the existing population in the genetic algorithm, a new population is generated based on the existing population, and the new population is used as the new round of iterative data group; Determine whether the new round of iterative data group meets the iteration termination condition. If so, use the new round of iterative data group as the optimized iterative data group. Otherwise, use the new round of iterative data group as the current iterative data group and obtain the new round of iterative data group based on the current iterative data group.

4. The design method according to claim 3, characterized in that: The current iterative data group is used as the existing population in the genetic algorithm, a new population is generated based on the existing population, and the new population is used as the new round of iterative data group including: The current iterative data group is used as the existing population in the genetic algorithm, and based on the fitness value of the dose distribution regulator data, some dose distribution regulator data are selected from the existing population for crossover mutation to obtain multiple dose distribution regulator data after crossover mutation, and based on the fitness value of the dose distribution regulator data, some dose distribution regulator data are selected from the existing population and all the dose distribution regulator data after crossover mutation to form a new population, and the new population is used as a new round of iterative data group.

5. The design method according to claim 4, characterized in that: Based on the fitness value of the dose distribution regulator data, some dose distribution regulator data are selected from the existing population for crossover mutation, including: Based on the fitness value in ascending order, multiple dose distribution regulator data are screened from the existing population, the material types of the multiple dose distribution regulator data are crossed and mutated, and the material thickness of the multiple dose distribution regulator data after the material type cross-mutation is crossed and mutated.

6. The design method according to claim 3, characterized in that: The iteration termination condition is that the current iteration number is greater than a preset iteration number or there is dose distribution adjuster data with a fitness value greater than a preset fitness threshold in the new round of iteration data group.

7. A storage medium having a computer program stored thereon, characterized in that: When the program is executed by a processor, the method for designing a dose distribution displacement device for BNCT as described in any one of claims 1 to 6 is implemented.

8. A terminal, characterized in that: include: A processor and a memory, wherein the memory is communicatively connected to the processor; The memory is used to store a computer program, and the processor is used to execute the computer program stored in the memory, so that the terminal executes the method for designing a dose distribution displacement device for BNCT as described in any one of claims 1 to 6.

9. A computer program product, comprising a computer program, characterized in that When the computer program is executed by a processor, the method for designing a dose distribution displacement device for BNCT according to any one of claims 1 to 6 is implemented.